InvestorsHub Logo
Followers 0
Posts 1610
Boards Moderated 0
Alias Born 03/14/2013

Re: CherryTree1 post# 183263

Thursday, 07/19/2018 10:20:04 AM

Thursday, July 19, 2018 10:20:04 AM

Post# of 701493
Nice spin on a .21 cent stock.

If they had any foresight at all they would have financed all they needed to get through this when the stock was at $12. They fully underestimated what small biotechs go through. If they were at all capable they would have known this.

No one in management had enough experience to prepare for what was about to happen. And that alone is why they should not be paid the big bucks. They have a great product but didn't know what to do with it. Hence all the silence when things started to go south.

Have you read any of the PR's prior to their silence? How about the approval in Switzerland? Go through the PR's on their website. How many of them actually deal with any science?

I have over 400k shares. I may be long, but I don't have to be happy about what has went on here and just be all rah rah rah...

Who is not doing well?
They have navigated through a fire storm of vicious attacks by powerful forces with huge resources and motivation to take them down and are still afloat.
They restructured the trial multiple times and effectively dealt with false progress, an FDA hold, dozen of bogus lawsuits, securing continued financing, etc . . .
The trial is taking far longer than any of us imagined or wanted but looks like it is on course for approval with eye popping Overall Survival stats.
Everyone should be raving about their management of these savage attacks that are preventing and delaying what appears to be effectively a cure for > 30% of the GBM patients is really unconscionable.
This will be a Harvard Business School case study some day on how a small bio start up successful gained approval when many others in this situation have failed in the past.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News